Hellp syndrome and composite major maternal morbidity: Importance of Mississippi classification system

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 12, 2013, Pages 1201-1206

  Martin, James N ^a   Brewer, Justin M ^a   Wallace, Kedra ^a   Sunesara, Imran ^b   Canizaro, Ashley ^a   Blake, Pamela G ^a   Lamarca, Babbette ^a   Owens, Michelle Y ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Dexamethasone; Edema; Maternal morbidity; Mississippi protocol; Severe preeclampsia

Indexed keywords

CREATININE; DEXAMETHASONE; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; NIFEDIPINE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; ASSISTED VENTILATION; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; ERYTHROCYTE TRANSFUSION; FEMALE; HEART INFARCTION; HELLP SYNDROME; HUMAN; INTENSIVE CARE; INTUBATION; LOADING DRUG DOSE; LUNG EDEMA; MAJOR CLINICAL STUDY; MATERNAL CARE; MATERNAL MORBIDITY; MISSISSIPPI CLASSIFICATION SYSTEM; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PERICARDIAL EFFUSION; PREECLAMPSIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC HYPERTENSION;

EID: 84880301937     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.773308     Document Type: Article

References (20)

1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159-67.
2. Sibai BM, Taslimi MM, El-Nazer A, et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia. Am J Obstet Gynecol 1986;155:501-9.
3. Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6.
4. Martin Jr JN, Blake PG, Lowry SL, et al. Pregnancy complicated by preeclampsia-eclampsia with syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery? Obstet Gynecol 1990;76:737-41.
5. Martin Jr JN, Blake PG, Perry Jr KG, et al. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991;164:1500-9.
6. Martin Jr JN, Magann EF, Blake PG, et al. Severe preeclampsia/eclampsia with HELLP syndrome in 454 pregnancies: comparative analysis using the 3-class system of classification. SMFM Abstract in Am J Obstet Gynecol 1993;168:266.
7. Magann EF, Bass D, Chauhan SP, et al. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1148-53.
8. Magann EF, Perry Jr KG, Meydrech EF, et al. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1154-8.
9. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460-4.
10. Martin Jr JN, Thigpen BD, Rose CH, et al. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Amer J Obstet Gynecol 2003;189:830-4.
11. Martin Jr JN, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006; 195:914-34.
12. Martin Jr JN, Owens MY, Keiser SD, et al. Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hyperten Pregnancy 2012;31:79-90.
13. Martin Jr JN, Rinehart BK, May WL, et al. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999;180:1373-84.
14. Darby M, Martin Jr JN, Mitchell SQ, Owens MY. Liver bleeding in patients with HELLP syndrome: pathogenesis and implications for preventive therapy. (Submitted for publication 2012).
15. Diagnosis and Management of Preeclampsia and Eclampsia. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin Number 33; January 2002.
16. Owens MY, Martin Jr JN, Wallace K, et al. Postpartum thrombotic microangiopathic syndrome (PTMS): a recognizable clinical scenario common to multiple uncommon diseases requiring plasma exchange to enable recovery. Transfus Apher Sci 2012 June 13 (epub ahead of print). PMID:22704633.
17. Abbade JF, Peracoli JC, Costa RAA, et al. Partial HELLP syndrome: maternal and perinatal outcome. Sao Paulo Med J 2002;120:180-4.
18. Liu C-M, Change S-D, Cheng P-J, Chao A-S. Comparisons of maternal and perinatal outcomes inTaiwanesewomen with complete and partial HELLP syndrome and women with severe preeclampsia without HELLP. J Obstet Gynaecol Res 2006;32:550-8.
19. Wang Y-Q, Wang J, Ye R-H, Zhao Y-Y. Investigation of diagnosis and treatment of hemolysis-elevated liver enzymes-low platelet counts (HELLP) syndrome: clinical analysis of 59 cases. Chin Med J 2010;123:1273-7.
20. Keiser SD, Owens MY, Parrish MR, et al. HELLP syndrome with and without eclampsia. Am J Perinatol 2011;28:187-94.